- Home
- RCUS vs MSC Comparison
RCUS vs MSC Comparison
Compare RCUS & MSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCUS
- MSC
- Stock Information
- Founded
- RCUS 2015
- MSC 2000
- Country
- RCUS United States
- MSC Hong Kong
- Employees
- RCUS N/A
- MSC N/A
- Industry
- RCUS Biotechnology: Pharmaceutical Preparations
- MSC Hotels/Resorts
- Sector
- RCUS Health Care
- MSC Consumer Discretionary
- Exchange
- RCUS Nasdaq
- MSC Nasdaq
- Market Cap
- RCUS 1.2B
- MSC 1.0B
- IPO Year
- RCUS 2018
- MSC 2018
- Fundamental
- Price
- RCUS $11.07
- MSC $3.98
- Analyst Decision
- RCUS Buy
- MSC
- Analyst Count
- RCUS 11
- MSC 0
- Target Price
- RCUS $31.11
- MSC N/A
- AVG Volume (30 Days)
- RCUS 1.1M
- MSC 13.7K
- Earning Date
- RCUS 02-25-2025
- MSC 03-03-2025
- Dividend Yield
- RCUS N/A
- MSC N/A
- EPS Growth
- RCUS N/A
- MSC N/A
- EPS
- RCUS N/A
- MSC N/A
- Revenue
- RCUS $263,000,000.00
- MSC $627,533,000.00
- Revenue This Year
- RCUS $127.65
- MSC $33.86
- Revenue Next Year
- RCUS N/A
- MSC $16.73
- P/E Ratio
- RCUS N/A
- MSC N/A
- Revenue Growth
- RCUS 119.17
- MSC 103.40
- 52 Week Low
- RCUS $10.63
- MSC $3.50
- 52 Week High
- RCUS $20.31
- MSC $9.30
- Technical
- Relative Strength Index (RSI)
- RCUS 34.34
- MSC 43.63
- Support Level
- RCUS $10.63
- MSC $3.50
- Resistance Level
- RCUS $13.49
- MSC $4.34
- Average True Range (ATR)
- RCUS 0.77
- MSC 0.41
- MACD
- RCUS -0.13
- MSC 0.06
- Stochastic Oscillator
- RCUS 13.88
- MSC 33.10
About RCUS Arcus Biosciences Inc.
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.
About MSC Studio City International Holdings Limited
Studio City International Holdings Ltd is a gaming, retail, and entertainment resort located in Cotai, Macau. It operates Studio City Casino with around 250 mass-market gaming tables; including 15 tables for VIP rolling chip operations, and 552 gaming machines. Studio City features luxury hotel rooms, diverse food and beverage establishments, and complementary retail space. In addition, the company offers non-gaming attractions, including the world's first figure-8 Ferris wheel, a deluxe nightclub and karaoke venue, a live performance arena, an outdoor and an indoor water park. Geographically, the company derives the majority of its revenue from the Macau region.